iohexol has been researched along with everolimus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Beckmann, MW; Brauweiler, R; Dittrich, R; Eisa, F; Hoffmann, I; Hupfer, M; Jost, G; Kalender, WA; Lotz, L; Nowak, T; Pietsch, H; Wachter, D | 1 |
Akasaka, T; Hirata, K; Imanishi, T; Ino, Y; Kitabata, H; Komukai, K; Kubo, T; Liu, Y; Matsuo, Y; Orii, M; Satogami, K; Shimamura, K; Shiono, Y; Tanaka, A; Tanimoto, T; Yamaguchi, T; Yamano, T | 1 |
3 other study(ies) available for iohexol and everolimus
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Dynamic contrast-enhanced micro-CT on mice with mammary carcinoma for the assessment of antiangiogenic therapy response.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Contrast Media; Everolimus; Female; Imaging, Three-Dimensional; Iohexol; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Reproducibility of Results; Sensitivity and Specificity; Sirolimus; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Comparison of vascular response between everolimus-eluting stent and bare metal stent implantation in ST-segment elevation myocardial infarction assessed by optical coherence tomography.
Topics: Aged; Contrast Media; Coronary Angiography; Drug-Eluting Stents; Everolimus; Female; Humans; Iohexol; Male; Myocardial Infarction; Prospective Studies; Risk Factors; Stents; Tomography, Optical Coherence; Treatment Outcome | 2015 |